Clinical Trials in Nashville

Showing 6261-6280 of 15,379 trials

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

NCT00463554

The primary objective of this study is to obtain clinical performance information on the GYNECARE TVT-SECUR\* System (Tension-free Support for Incontinence) in women with stress urinary incontinence (SUI).

Stress Urinary Incontinence

Ethicon, Inc.72 participantsStarted Apr 2006

Dearborn, Michigan, United States • Cincinnati, Ohio, United States • Allentown, Pennsylvania, United States +3 more locations

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

NCT04196491

This is a multicenter, open-label, phase 1, single arm study intended to determine the optimal target dose and safety of bb2121 in subjects with HR (R-ISS Stage III per IMWG criteria) NDMM. Subjects should have received 3 Cycles of standard induction therapy prior to undergoing leukapheresis procedure to collect autologous mononuclear cells for manufacture of the drug product (bb2121). Following manufacture of the drug product, subjects will receive fourth cycle of induction therapy followed by lymphodepleting therapy with fludarabine and cyclophosphamide prior to bb2121 infusion. Maintenance therapy is recommended for all subjects who have received bb2121 infusion and should be initiated upon adequate bone marrow recovery or from 90-day post-bb2121 infusion, whichever is later.

Multiple Myeloma

Celgene13 participantsStarted May 2020

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +19 more locations

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Find Trials by Condition in Nashville

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Safety and Tolerability of Repeat Courses of IM Alefacept

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

BioVentrix Revivent TC™ System Clinical Study

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma

Study of Sargramostim in Patients With COVID-19

A Dose Finding Study to Treat Bone Tumor(s)

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

The Effect of the Erchonia GVL Low Level Laser Therapy on Neck and Shoulder Pain

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome